Global Antiemetics Market Size, Share, Growth, Sales, and Forecasts 2034
Antiemetics Market By Indication (Motion Sickness, Chemotherapy-Induced Nausea, Pregnancy-related Nausea, Postoperative Nausea & Vomiting, and Radiation-Infused Nausea), By Route of Administration (Rectal, Transdermal, Oral, Intravenous, and Subcutaneous), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034
Category: Healthcare Report Format : PDF
Pages: 214 Report Code: ZMR-10298
Published Date: Feb-2026 Status : Published
| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 37.54 Billion | USD 59.27 Billion | 4.24% | 2024 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Antiemetics Market, (2025 - 2034) (USD Billion)
- 2.2 Global Antiemetics Market : snapshot
- Chapter 3. Global Antiemetics Market - Industry Analysis
- 3.1 Antiemetics Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Surging cases of cancer worldwide to propel market expansion during the projection period
- 3.3 Market Restraints
- 3.3.1. Drug side effects restrict antiemetics market growth trends in the coming years
- 3.4 Market Opportunities
- 3.4.1. Ongoing advancements in antiemetics create growth opportunities in the future
- 3.5 Market Challenges
- 3.5.1. The growth possibilities offered to antiemetics industry by the increasing demand for ambulatory services
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Indication
- 3.7.2 Market attractiveness analysis By Route of Administration
- Chapter 4. Global Antiemetics Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Antiemetics Market: company market share, 2024
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Antiemetics Market - Indication Analysis
- 5.1 Global Antiemetics Market overview: By Indication
- 5.1.1 Global Antiemetics Market share, By Indication, 2024 and 2034
- 5.2 Motion Sickness
- 5.2.1 Global Antiemetics Market by Motion Sickness, 2025 - 2034 (USD Billion)
- 5.3 Chemotherapy-Induced Nausea
- 5.3.1 Global Antiemetics Market by Chemotherapy-Induced Nausea, 2025 - 2034 (USD Billion)
- 5.4 Pregnancy-related Nausea
- 5.4.1 Global Antiemetics Market by Pregnancy-related Nausea, 2025 - 2034 (USD Billion)
- 5.5 Postoperative Nausea & Vomiting
- 5.5.1 Global Antiemetics Market by Postoperative Nausea & Vomiting, 2025 - 2034 (USD Billion)
- 5.6 Radiation-Infused Nausea
- 5.6.1 Global Antiemetics Market by Radiation-Infused Nausea, 2025 - 2034 (USD Billion)
- 5.1 Global Antiemetics Market overview: By Indication
- Chapter 6. Global Antiemetics Market - Route of Administration Analysis
- 6.1 Global Antiemetics Market overview: By Route of Administration
- 6.1.1 Global Antiemetics Market share, By Route of Administration, 2024 and 2034
- 6.2 Rectal
- 6.2.1 Global Antiemetics Market by Rectal, 2025 - 2034 (USD Billion)
- 6.3 Transdermal
- 6.3.1 Global Antiemetics Market by Transdermal, 2025 - 2034 (USD Billion)
- 6.4 Oral
- 6.4.1 Global Antiemetics Market by Oral, 2025 - 2034 (USD Billion)
- 6.5 Intravenous
- 6.5.1 Global Antiemetics Market by Intravenous, 2025 - 2034 (USD Billion)
- 6.6 Subcutaneous
- 6.6.1 Global Antiemetics Market by Subcutaneous, 2025 - 2034 (USD Billion)
- 6.1 Global Antiemetics Market overview: By Route of Administration
- Chapter 7. Antiemetics Market - Regional Analysis
- 7.1 Global Antiemetics Market Regional Overview
- 7.2 Global Antiemetics Market Share, by Region, 2024 & 2034 (USD Billion)
- 7.3. North America
- 7.3.1 North America Antiemetics Market, 2025 - 2034 (USD Billion)
- 7.3.1.1 North America Antiemetics Market, by Country, 2025 - 2034 (USD Billion)
- 7.3.1 North America Antiemetics Market, 2025 - 2034 (USD Billion)
- 7.4 North America Antiemetics Market, by Indication, 2025 - 2034
- 7.4.1 North America Antiemetics Market, by Indication, 2025 - 2034 (USD Billion)
- 7.5 North America Antiemetics Market, by Route of Administration, 2025 - 2034
- 7.5.1 North America Antiemetics Market, by Route of Administration, 2025 - 2034 (USD Billion)
- 7.4. Europe
- 7.4.2 Europe Antiemetics Market, 2025 - 2034 (USD Billion)
- 7.4.2.1 Europe Antiemetics Market, by Country, 2025 - 2034 (USD Billion)
- 7.4.2 Europe Antiemetics Market, 2025 - 2034 (USD Billion)
- 7.4 Europe Antiemetics Market, by Indication, 2025 - 2034
- 7.4.1 Europe Antiemetics Market, by Indication, 2025 - 2034 (USD Billion)
- 7.5 Europe Antiemetics Market, by Route of Administration, 2025 - 2034
- 7.5.1 Europe Antiemetics Market, by Route of Administration, 2025 - 2034 (USD Billion)
- 7.5. Asia Pacific
- 7.5.3 Asia Pacific Antiemetics Market, 2025 - 2034 (USD Billion)
- 7.5.3.1 Asia Pacific Antiemetics Market, by Country, 2025 - 2034 (USD Billion)
- 7.5.3 Asia Pacific Antiemetics Market, 2025 - 2034 (USD Billion)
- 7.4 Asia Pacific Antiemetics Market, by Indication, 2025 - 2034
- 7.4.1 Asia Pacific Antiemetics Market, by Indication, 2025 - 2034 (USD Billion)
- 7.5 Asia Pacific Antiemetics Market, by Route of Administration, 2025 - 2034
- 7.5.1 Asia Pacific Antiemetics Market, by Route of Administration, 2025 - 2034 (USD Billion)
- 7.6. Latin America
- 7.6.4 Latin America Antiemetics Market, 2025 - 2034 (USD Billion)
- 7.6.4.1 Latin America Antiemetics Market, by Country, 2025 - 2034 (USD Billion)
- 7.6.4 Latin America Antiemetics Market, 2025 - 2034 (USD Billion)
- 7.4 Latin America Antiemetics Market, by Indication, 2025 - 2034
- 7.4.1 Latin America Antiemetics Market, by Indication, 2025 - 2034 (USD Billion)
- 7.5 Latin America Antiemetics Market, by Route of Administration, 2025 - 2034
- 7.5.1 Latin America Antiemetics Market, by Route of Administration, 2025 - 2034 (USD Billion)
- 7.7. The Middle-East and Africa
- 7.7.5 The Middle-East and Africa Antiemetics Market, 2025 - 2034 (USD Billion)
- 7.7.5.1 The Middle-East and Africa Antiemetics Market, by Country, 2025 - 2034 (USD Billion)
- 7.7.5 The Middle-East and Africa Antiemetics Market, 2025 - 2034 (USD Billion)
- 7.4 The Middle-East and Africa Antiemetics Market, by Indication, 2025 - 2034
- 7.4.1 The Middle-East and Africa Antiemetics Market, by Indication, 2025 - 2034 (USD Billion)
- 7.5 The Middle-East and Africa Antiemetics Market, by Route of Administration, 2025 - 2034
- 7.5.1 The Middle-East and Africa Antiemetics Market, by Route of Administration, 2025 - 2034 (USD Billion)
- Chapter 8. Company Profiles
- 8.1 Metoclopramide
- 8.1.1 Overview
- 8.1.2 Financials
- 8.1.3 Product Portfolio
- 8.1.4 Business Strategy
- 8.1.5 Recent Developments
- 8.2 Ondansetron
- 8.2.1 Overview
- 8.2.2 Financials
- 8.2.3 Product Portfolio
- 8.2.4 Business Strategy
- 8.2.5 Recent Developments
- 8.3 Palonosetron
- 8.3.1 Overview
- 8.3.2 Financials
- 8.3.3 Product Portfolio
- 8.3.4 Business Strategy
- 8.3.5 Recent Developments
- 8.4 Promethazine
- 8.4.1 Overview
- 8.4.2 Financials
- 8.4.3 Product Portfolio
- 8.4.4 Business Strategy
- 8.4.5 Recent Developments
- 8.5 Meclizine
- 8.5.1 Overview
- 8.5.2 Financials
- 8.5.3 Product Portfolio
- 8.5.4 Business Strategy
- 8.5.5 Recent Developments
- 8.6 Domperidone
- 8.6.1 Overview
- 8.6.2 Financials
- 8.6.3 Product Portfolio
- 8.6.4 Business Strategy
- 8.6.5 Recent Developments
- 8.7 Dolasetron
- 8.7.1 Overview
- 8.7.2 Financials
- 8.7.3 Product Portfolio
- 8.7.4 Business Strategy
- 8.7.5 Recent Developments
- 8.8 Diphenhydramine
- 8.8.1 Overview
- 8.8.2 Financials
- 8.8.3 Product Portfolio
- 8.8.4 Business Strategy
- 8.8.5 Recent Developments
- 8.9 Olanzapine
- 8.9.1 Overview
- 8.9.2 Financials
- 8.9.3 Product Portfolio
- 8.9.4 Business Strategy
- 8.9.5 Recent Developments
- 8.10 Granisetron
- 8.10.1 Overview
- 8.10.2 Financials
- 8.10.3 Product Portfolio
- 8.10.4 Business Strategy
- 8.10.5 Recent Developments
- 8.11 Dexamethasone
- 8.11.1 Overview
- 8.11.2 Financials
- 8.11.3 Product Portfolio
- 8.11.4 Business Strategy
- 8.11.5 Recent Developments
- 8.12 Aprepitant
- 8.12.1 Overview
- 8.12.2 Financials
- 8.12.3 Product Portfolio
- 8.12.4 Business Strategy
- 8.12.5 Recent Developments
- 8.13 Dimenhydrinate
- 8.13.1 Overview
- 8.13.2 Financials
- 8.13.3 Product Portfolio
- 8.13.4 Business Strategy
- 8.13.5 Recent Developments
- 8.14 Scopolamine
- 8.14.1 Overview
- 8.14.2 Financials
- 8.14.3 Product Portfolio
- 8.14.4 Business Strategy
- 8.14.5 Recent Developments
- 8.15 Prochlorperazine
- 8.15.1 Overview
- 8.15.2 Financials
- 8.15.3 Product Portfolio
- 8.15.4 Business Strategy
- 8.15.5 Recent Developments
- 8.16 and others.
- 8.16.1 Overview
- 8.16.2 Financials
- 8.16.3 Product Portfolio
- 8.16.4 Business Strategy
- 8.16.5 Recent Developments
- 8.1 Metoclopramide
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global Antiemetics Market, 2025 - 2034 (USD Billion)
- 4. Porter’s Five Forces Analysis
- 5. Global Antiemetics Market attractiveness, By Indication
- 6. Global Antiemetics Market attractiveness, By Route of Administration
- 7. Global Antiemetics Market share by Indication, 2025 and 2034 (USD Billion)
- 8. Global Antiemetics Market by Motion Sickness, 2025 - 2034 (USD Billion)
- 9. Global Antiemetics Market by Chemotherapy-Induced Nausea, 2025 - 2034 (USD Billion)
- 10. Global Antiemetics Market by Pregnancy-related Nausea, 2025 - 2034 (USD Billion)
- 11. Global Antiemetics Market by Postoperative Nausea & Vomiting, 2025 - 2034 (USD Billion)
- 12. Global Antiemetics Market by Radiation-Infused Nausea, 2025 - 2034 (USD Billion)
- 13. Global Antiemetics Market share by Route of Administration, 2025 and 2034 (USD Billion)
- 14. Global Antiemetics Market by Rectal, 2025 - 2034 (USD Billion)
- 15. Global Antiemetics Market by Transdermal, 2025 - 2034 (USD Billion)
- 16. Global Antiemetics Market by Oral, 2025 - 2034 (USD Billion)
- 17. Global Antiemetics Market by Intravenous, 2025 - 2034 (USD Billion)
- 18. Global Antiemetics Market by Subcutaneous, 2025 - 2034 (USD Billion)
- 19. Global Antiemetics Market share, by Region, 2025 and 2034
- 20. North America Antiemetics Market, 2025 - 2034 (USD Billion)
- 21. Europe Antiemetics Market, 2025 - 2034 (USD Billion)
- 22. Asia Pacific Antiemetics Market, 2025 - 2034 (USD Billion)
- 23. Latin America Antiemetics Market, 2025 - 2034 (USD Billion)
- 24. The Middle-East and Africa Antiemetics Market, 2025 - 2034 (USD Billion)
Table Of Tables
- 1. Global Antiemetics Market: Snapshot
- 2. Drivers of the Antiemetics Market: impact analysis
- 3. North America Antiemetics Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 4. North America Antiemetics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 5. U.S. Antiemetics Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 6. U.S. Antiemetics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 7. Canada Antiemetics Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 8. Canada Antiemetics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 9. Europe Antiemetics Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 10. Europe Antiemetics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 11. Germany Antiemetics Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 12. Germany Antiemetics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 13. France Antiemetics Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 14. France Antiemetics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 15. U.K. Antiemetics Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 16. U.K. Antiemetics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 17. Italy Antiemetics Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 18. Italy Antiemetics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 19. Spain Antiemetics Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 20. Spain Antiemetics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 21. Rest of Europe Antiemetics Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 22. Rest of Europe Antiemetics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 23. Asia Pacific Antiemetics Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 24. Asia Pacific Antiemetics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 25. China Antiemetics Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 26. China Antiemetics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 27. Japan Antiemetics Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 28. Japan Antiemetics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 29. India Antiemetics Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 30. India Antiemetics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 31. South Korea Antiemetics Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 32. South Korea Antiemetics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 33. South-East Asia Antiemetics Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 34. South-East Asia Antiemetics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 35. Rest of Asia Pacific Antiemetics Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 36. Rest of Asia Pacific Antiemetics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 37. Latin America Antiemetics Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 38. Latin America Antiemetics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 39. Brazil Antiemetics Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 40. Brazil Antiemetics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 41. Mexico Antiemetics Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 42. Mexico Antiemetics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 43. Rest of Latin America Antiemetics Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 44. Rest of Latin America Antiemetics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 45. The Middle-East and Africa Antiemetics Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 46. The Middle-East and Africa Antiemetics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 47. GCC Countries Antiemetics Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 48. GCC Countries Antiemetics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 49. South Africa Antiemetics Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 50. South Africa Antiemetics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
- 51. Rest of Middle-East Africa Antiemetics Market revenue, By Indication, 2025 - 2034 (USD Billion)
- 52. Rest of Middle-East Africa Antiemetics Market revenue, By Route of Administration, 2025 - 2034 (USD Billion)
Methodology
FrequentlyAsked Questions
Antiemetics are medical drugs used to treat vomiting and nausea. Antiemetics are divided into 7 main subgroups, including cannabinoids, antihistamines, and serotonin antagonists.
The global antiemetic market is expected to be driven by the rising geriatric population across the globe.
According to study, the global antiemetics market size was worth around USD 37.54 billion in 2024 and is predicted to grow to around USD 59.27 billion by 2034.
The CAGR value of the antiemetics market is expected to be around 4.24% during 2025-2034.
The global antiemetics market is expected to be challenged by the regulatory hurdles that exist in the industry.
Increased demand for personalized medicines, demand for preventive care, and technological integration in drug discovery are the emerging trends and innovations impacting the antiemetics market.
The global antiemetics market has shown steady growth in the current period and is expected to follow the same trends in the coming years.
The global antiemetics market is expected to be led by North America during the forecast period.
The global antiemetics market is led by players like Metoclopramide, Ondansetron, Palonosetron, Promethazine, Meclizine, Domperidone, Dolasetron, Diphenhydramine, Olanzapine, Granisetron, Dexamethasone, Aprepitant, Dimenhydrinate, Scopolamine, and Prochlorperazine.
The report explores crucial aspects of the antiemetics market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
HappyClients
